Page last updated: 2024-10-31

mitoxantrone and Diabetes Insipidus, Neurogenic

mitoxantrone has been researched along with Diabetes Insipidus, Neurogenic in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Diabetes Insipidus, Neurogenic: A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vyas, V1
Shah, SA1
Patel, KM1
Parekh, BB1
Nath, SV1
Hussain, BM1

Other Studies

1 other study available for mitoxantrone and Diabetes Insipidus, Neurogenic

ArticleYear
Acute lymphocytic leukemia CNS disease presenting as central diabetes insipidus.
    The Journal of the Association of Physicians of India, 2002, Volume: 50

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Chlorambucil; Deamino Arginine Vasopre

2002